link to page 1 
Updated February 6, 2020
Novel Coronavirus (2019-nCoV): Developments in China and
International Response
Overview
breath. Of roughly 25,000 2019-nCoV cases identified
On December 31, 2019, China’s government notified the
worldwide as of February 5, WHO reports more than 3,200
World Health Organization (WHO) of patients with
are severely ill and almost 500 have died. The outbreak
pneumonia of unknown cause in Wuhan, China. On January
remains concentrated in China, with less than 200 of all
7, 2020, Chinese scientists isolated a previously unknown
cases and two deaths having been detected outside
coronavirus (2019-nCoV) in the patients, and on January 12
mainland China. Health experts are still seeking to
made its genetic sequence available to WHO and
understand the origins of the disease and its epidemiology,
international partners. By February 5, the virus had spread
including the intensity of human-to-human transmission.
to every province in China and to 24 other countries (see
No specific treatments or vaccines are available for 2019-
Figure 1). The outbreak remains concentrated in China,
nCoV. Scientists from around the world, including the
with fewer than 200 of all cases having occurred outside of
United States, China, Russia, and Australia, are reportedly
the country. As required by the International Health
working to develop 2019-nCoV diagnostic tests, treatments,
Regulations (IHR), a binding international law on global
and vaccines. WHO has developed a disease commodity
health security, countries are closely monitoring and
package that lists essential biomedical equipment,
reporting emergent 2019-nCoV cases. WHO is coordinating
medicines, and supplies needed for 2019-nCoV care. The
the global response; the United States is aiding as a member
U.S. National Institutes of Health (NIH) indicated in late
of WHO and through its own agencies, such as the U.S.
January that a candidate vaccine for 2019-nCoV could be
Centers for Disease Control and Prevention (CDC). (See
ready for early-stage human testing within three months,
CRS In Focus IF10022, The Global Health Security Agenda
compared to the 20 months it took to begin early-state
and International Health Regulations, and CRS Insight
development of an investigational SARS vaccine.
IN11212, Another Coronavirus Emerges: U.S. Domestic
Response to 2019-nCoV.)
Developments in China
In 2002-2003, China’s government was widely criticized
The Virus: 2019-nCoV
for initially covering up the SARS outbreak. Critics have
Coronaviruses are a large family of zoonotic viruses
faulted China for suppressing critical information about the
(viruses transmissible between animals and humans) that
2019-nCoV outbreak in its early stages too. They suggest
can cause illness ranging from the common cold to more
China may have squandered a window of opportunity when
severe diseases such as Middle-East Respiratory Syndrome
an informed Wuhan populace could have potentially
(MERS) and Severe Acute Respiratory Syndrome (SARS).
changed its behavior to limit the virus’s spread. WHO
The most common symptoms among confirmed 2019-
nCoV patients include fever, cough, and shortness of
Figure 1. Locations with Confirmed 2019-nCoV Cases Globally, as of February 5, 2020
Source: Centers for Disease Control and Prevention, https://www.cdc.gov/coronavirus/2019-ncov/locations-confirmed-cases.html.
Director-General Tedros Ghebreyesus has, however,
isolated the virus, sequenced the genome and shared it”
praised “the speed with which China detected the outbreak,
with the world.
https://crsreports.congress.gov
Novel Coronavirus (2019-nCoV): Developments in China and International Response
Wuhan authorities say the first patient later found to be
15-member IHR Emergency Committee for Pneumonia due
suffering from “pneumonia of an unknown cause” was
to the Novel Coronavirus 2019-nCoV, which includes a
hospitalized on December 12, 2019. Wuhan’s Health
CDC representative, Dr. Martin Cetron. The committee
Commission first acknowledged the outbreak publicly on
agreed on the “urgency of the situation” and said it would
December 30, and Chinese authorities alerted WHO of the
reconvene on January 30, at which time the committee
cases the next day. From January 1 to January 19, 2020,
concluded the outbreak had become a PHEIC. The same
however, Wuhan authorities publicly downplayed the
day, WHO Director-General Tedros issued a PHEIC
outbreak. They asserted “no clear evidence of person-to-
declaration, prompting countries to take specific actions,
person transmission,” and from January 11-16 reported a
including heightening surveillance and reporting of the
constant 41 known 2019-nCoV infections. On January 1,
disease. In the case of the United States, Department of
Wuhan authorities announced they were investigating eight
Health and Human Services (HHS) Secretary Alex Azar
individuals for spreading “inaccurate information.” Those
declared “a public health emergency for the entire United
individuals were later revealed to be medical workers who
States to aid the nation’s healthcare community in
had sought to warn others about the outbreak.
responding to 2019 novel coronavirus.” He also announced
the department would make available up to $105 million
On January 20, China's leaders pivoted, abruptly elevating
from the Infectious Disease Rapid Response Reserve Fund
containment of the virus to an urgent national priority. That
for domestic and international 2019-nCoV responses. A
day, state media quoted a renowned doctor as saying for the
PHEIC declaration can also prompt countries to provide
first time that the virus could be transmitted from person-to-
person. China’s N
additional resources for global and domestic response and
ational Health Commission declared
“novel coronavirus
enable WHO to access certain emergency funding, such as
-caused pneumonia” a statutory
infectious disease under China’s Law on the Prevention and
from the United Nations (U.N.) Central Emergency
Response Fund (CERF) and the World Bank Pandemic
Treatment of Infectious Diseases, triggering prevention and
Emergency Financing Facility (PEF).
control measures.
Following a January 28 meeting in Beijing between
On January 23, the day before Lunar New Year’s Eve,
Chinese President Xi Jinping and the WHO Director-
Wuhan, a city of 11 million people and a major national
General, China accepted WHO’s offer to send a team to
transport hub, abruptly announced it was suspending public
China to work with Chinese counterparts on 2019-nCoV
transportation and sealing off the city. Other cities across
outbreak control. Plans are underway for the delegation,
Hubei Province rapidly instituted their own travel
which is to include the CDC. On February 5, the WHO
restrictions, putting much of the province of 59 million
announced a $675 million 2019-nCoV preparedness plan
people in a de facto lockdown. Both the scale and the speed
for February through April. The plan aims to provide
of the lockdown are unprecedented globally. On January
international coordination and operational support, bolster
27, Wuhan Mayor Zhou Xianwang acknowledged that
country readiness and response capacity (particularly in
approximately 5 million residents left his city before the
low-resource countries), and accelerate relevant research
travel restrictions went into place. The disclosure raised
and innovation.
questions about how effective the later move to seal off the
city would be in stemming spread of the virus. The mayor
U.S. Response
also acknowledged that he had not disclosed information
On January 29, President Donald Trump announced the
“in a timely manner” and implicitly blamed China’s central
formation of the President’s Coronavirus Task Force, led by
government. He said Chinese law restricted Wuhan from
HHS and coordinated by the National Security Council.
sharing information without permission from higher-ups.
The Department of Homeland Security has issued
China’s
instructions for quarantining U.S. citizens and permanent
Premier Li Keqiang is leading a new Communist
residents returning to the United States after stays in China,
Party committee on controlling the virus. Hubei hospitals
and barring the entry of other foreigners with recent travel
are struggling with shortages of staff and supplies; they are
to China. China has criticized those measures and called on
reportedly unable to screen everyone seeking care. Across
the United States to “react in an objective, fair, calm and
China, schools and workplaces have delayed reopening
evidence-based manner, rather than excessively.” CDC
after the holiday to limit person-to-person transmission.
experts will be part of the China-WHO joint expert group
China has suspended all outbound overseas group tourism.
on 2019-nCoV.
Hong Kong, a Special Administrative Region of China, has
announced a compulsory 14-day quarantine for all arrivals
The State Department has evacuated nonemergency U.S.
from mainland China. Several of China’s neighbors,
personnel and their family members and private U.S.
including Mongolia, Nepal, North Korea, Russia,
citizens from Wuhan. It has also authorized the voluntary
Tajikistan, and Vietnam, have ordered partial closure of
departure of nonemergency personnel and family members
their land borders with China. Many international airlines
of U.S. government employees from other posts in China,
have reduced or suspended service to China.
and ordered the mandatory evacuation of family members
Global Cases and WHO Response
under age 21. The Department has issued a Level 4 (“Do
Not Travel”) advisory for China.
Following the emergence of a disease that might be deemed
a Public Health Emergency of International Concern
Sara M. Tharakan, Analyst in Global Health and
(PHEIC), WHO convenes an advisory group, known as the
International Development
IHR Emergency Committee, to review data and make
Susan V. Lawrence, Specialist in Asian Affairs
recommendations to the WHO Director-General related to
Tiaji Salaam-Blyther, Specialist in Global Health
the disease. On January 22, WHO convened a meeting of its
https://crsreports.congress.gov
Novel Coronavirus (2019-nCoV): Developments in China and International Response
IF11421
Disclaimer
This document was prepared by the Congressional Research Service (CRS). CRS serves as nonpartisan shared staff to
congressional committees and Members of Congress. It operates solely at the behest of and under the direction of Congress.
Information in a CRS Report should not be relied upon for purposes other than public understanding of information that has
been provided by CRS to Members of Congress in connection with CRS’s institutional role. CRS Reports, as a work of the
United States Government, are not subject to copyright protection in the United States. Any CRS Report may be
reproduced and distributed in its entirety without permission from CRS. However, as a CRS Report may include
copyrighted images or material from a third party, you may need to obtain the permission of the copyright holder if you
wish to copy or otherwise use copyrighted material.
https://crsreports.congress.gov | IF11421 · VERSION 3 · UPDATED